Table 1.
Survey results and DRLs: radiopharmaceuticals for scintigraphy
| Procedure and radiopharmaceutical | Median activity of radiopharmaceutical, MBq | 2020 DRLs, MBq | 2015 DRLs, MBq | |
|---|---|---|---|---|
| 50th percentile | 75th percentile | |||
| Bone: 99mTc-MDP | 879.9 | 951.2 | 950 | 950 |
| Bone: 99mTc-HMDP | 882.9 | 986.0 | 950 | 950 |
| Bone marrow: 111In-chloride | 76.0 | 76.9 | 80 | 120 |
| Cerebral blood flow: 99mTc-HM-PAO, rest or stress | 760.0 | 871.1 | 800 | 800 |
| Cerebral blood flow: 99mTc-HM-PAO, rest and stress | 1110.0 | 1116.0 | 1200 | 1200 |
| Cerebral blood flow: 99mTc-ECD, rest or stress | 755.0 | 796.5 | 800 | 800 |
| Cerebral blood flow: 99mTc-ECD, rest and stress | 1000.0 | 1088.0 | 1100 | 1100 |
| Cerebral blood flow: 123I-IMP, rest or stress | 183.0 | 206.1 | 200 | 200 |
| Cerebral blood flow: 123I-IMP, rest and stress | 249.8 | 272.0 | 270 | 300 |
| Benzodiazepine receptor: 123I-iomazenil | 185.0 | 195.5 | 200 | 200 |
| Dopamine transporter: 123I-ioflupane | 184.5 | 190.3 | 190 | 190 |
| Cisternography: 111In-DTPA | 38.0 | 38.2 | 40 | 70 |
| Thyroid imaging: Na123I | 8.1 | 8.7 | 10 | 10 |
| Thyroid imaging: 99mTc-O4− | 185.0 | 238.5 | 240 | 300 |
| Parathyroid: 201Tl- chloride | 75.7 | 111.6 | 120 | 120 |
| Parathyroid: 99mTc-O4− | 224.0 | 370.0 | 300 | 300 |
| Parathyroid: 99mTc-MIBI | 745.5 | 828.1 | 800 | 800 |
| Lung ventilation: 81mKr-gas | 185.0 | 190.6 | 200 | 200 |
| Lung perfusion: 99mTc-MAA | 201.0 | 280.0 | 260 | 260 |
| Venography: 99mTc-MAA | 370.0 | 477.5 | 500 | 500 |
| Liver and spleen: 99mTc-phytate | 185.0 | 200.0 | 200 | 200 |
| Liver function: 99mTc-GSA | 233.0 | 260.0 | 260 | 260 |
| Hepatobiliary: 99mTc-PMT | 233.0 | 260.0 | 260 | 260 |
| Liver and spleen: 99mTc-Sn colloid | 144.5 | 185.0 | 180 | 180 |
| Myocardial perfusion: 201Tl- chloride | 113.0 | 114.0 | 120 | 180 |
| Myocardial perfusion: 99mTc-tetrofosmin, rest or stress | 740.0 | 836.0 | 840 | 900 |
| Myocardial perfusion: 99mTc-tetrofosmin, rest and stress | 1077.2 | 1200.0 | 1200 | 1200 |
| Myocardial perfusion: 99mTc-MIBI, rest or stress | 755.2 | 874.6 | 880 | 900 |
| Myocardial perfusion: 99mTc-MIBI, rest and stress | 1076.4 | 1229.0 | 1200 | 1200 |
| Myocardial fatty acid metabolism: 123I-BMIPP | 124.0 | 129.1 | 130 | 130 |
| Cardiac sympathetic nerve imaging: 123I-MIBG | 126.0 | 129.9 | 130 | 130 |
| Cardiac blood pool: 99mTc-HSA-D | 835.0 | 966.0 | 970 | 1000 |
| Myocardial infarction: 99mTc-PYP | 740.0 | 809.5 | 800 | 800 |
| Salivary gland: 99mTc-O4− | 209.4 | 370.0 | 370 | 370 |
| Meckel's diverticulum: 99mTc-O4− | 370.0 | 432.8 | 440 | 500 |
| Gastrointestinal bleeding: 99mTc-HSA-D | 933.0 | 1045.0 | 1040 | 1040 |
| Protein losing gastroenteropathy: 99mTc-HSA-D | 932.0 | 1041.0 | 1040 | – |
| Renal imaging, static: 99mTc-DMSA | 185.0 | 212.8 | 210 | 210 |
| Renal imaging, dynamic: 99mTc-MAG3 | 286.5 | 375.6 | 380 | 400 |
| Renal imaging, dynamic: 99mTc-DTPA | 356.5 | 390.3 | 390 | 400 |
| Adrenal cortex: 131I-Adosterol | 37.0 | 39.4 | 40 | 44 |
| Adrenal medulla: 123I-MIBG | 128.1 | 132.4 | 130 | 130 |
| Tumor: 201Tl-chloride | 113.9 | 114.2 | 120 | 180 |
| Tumor and inflammation: 67Ga-citrate | 113.0 | 114.0 | 120 | 200 |
| Somatostatin receptor: 111In-pentetreotide | 156.0 | 185.7 | 120 | – |
| Lymphatic system: 99mTc-HSA-D | 440.0 | 830.0 | 830 | 950 |
| Sentinel lymph node, breast cancer: 99mTc colloid | 74.0 | 111.0 | 120 | 120 |
| Sentinel lymph node, breast cancer: 99mTc-phytate | 72.8 | 100.0 | 120 | 120 |
| Sentinel lymph node, melanoma: 99mTc colloid | 92.5 | 152.0 | 120 | 120 |
| Sentinel lymph node, melanoma: 99mTc-phytate | 78.0 | 111.0 | 120 | 120 |
| RI angiography: 99mTc-HSA-D | 932.0 | 1045.0 | 1000 | 1000 |